sickle cell disease
-
Vertex Casgevy wins landmark FDA approval for toddlers with SCD and TDT
The expanded label is expected to make about 5,500 additional children in the United States eligible for treatment.
-
JOOTRH deploys automated blood analyzer to cut transfusion screening to 35 minutes
The new technology can complete blood screening within 20 to 35 minutes using advanced antigen-antibody detection methods, enabling clinicians to access safe blood more quickly for emergency and routine transfusions.
-
African Union validates Continental Strategy to strengthen response to sickle cell disease
The continental framework outlines actions to expand newborn screening, early diagnosis, treatment, surveillance, financing, advocacy, local production of commodities, research, and integrated care systems.
-
JOOTRH becomes first Kenyan public hospital to own Spectra Optia Apheresis System
The Spectra Optia Apheresis Machine performs red cell exchange, a specialized procedure that removes damaged red blood cells from patients and replaces them with healthy ones.
-
JOOTRH introduces life-saving apheresis service for sickle cell patients
The new machine, now operational at the JOOTRH Victoria Annex, performs two crucial procedures: Therapeutic Plasma Exchange (TPE) and Red Blood Cell Exchange (RBC-X).